Decrease of Lesions Induced by Mechanical Ventilation During ARDS — ECMO-VILI  

ARDS, Human Clinical Trial

Official title: Reduction of Mechanical Ventilation-induced Lesions During ARDS With Multimodal Ultra-protective Ventilation in Combination With ECMO

Status Terminated

Clinical Trial Summary

Modification of mechanically ventilated lesions by an ultra-protective multimodal strategy compared to a protective strategy in patients with veno-venous ECMO for severe ARDS.

Clinical Trial Description

the hypothesis is that ECMO, in addition to improving gas exchange, should limit the deleterious effects of mechanical ventilation (mechanical ventilation-induced lesions, VILI) by drastically reducing minute ventilation (volume reduction). current, Vt, reduction of respiratory rate, reduction of mechanical power, reduction of motor pressure or driving pressure), adapting the level of PEEP from the data collected by monitoring oesophageal pressure and systematically performing positioning sessions in the prone position. This ultra-protective strategy could thus promote the restoration of the integrity of the alveolo-capillary membrane and thus facilitate the healing of patients. In order to verify this concept and, if necessary, to propose a study whose objectives would be more clinical (mortality, ventilator-free days), we propose to carry out a study aimed at showing that this ultra-protective multimodal strategy reduces the lesions induced by mechanical ventilation compared to usual protective ventilatory management during the ECMO as proposed in the EOLIA study. ;

Related Conditions & MeSH terms

• ARDS, Human
• Respiratory Distress Syndrome

• NCT number: NCT03918603
• Study type: Interventional
• Source: Assistance Publique Hopitaux De Marseille
• Status: Terminated
• Phase: N/A
• Start date: July 3, 2019
• Completion date: June 23, 2021